Results 271 to 280 of about 507,904 (333)
Some of the next articles are maybe not open access.
GROWTH HORMONE RELEASING FACTORS
Annual Review of Biochemistry, 1985PERSPECTIVES AND SUMMARy. . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 403 ISOLATION AND CHARACTERIZATION OF GRFs FROM TUMOR AND HYPOTHALAMIC TISSUE . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . 405 Tumor GRFs . .
N, Ling +7 more
openaire +2 more sources
Growth Hormone Releasing Hormone and Growth Hormone Releasing Peptides
1995The regulation of growth hormone (GH) secretion in humans is a complex entity involving primary regulators and secondary modifiers that influence both the amount and pattern of GH release. The primary regulators are the hypothalamic hormones: somatostatin (SRIH) and growth hormone releasing hormone (GHRH).
Mary Lee Vance +4 more
openaire +1 more source
Growth Hormone Releasing Hormone Receptor
Receptors and Channels, 2002Growth hormone releasing hormone receptor (GHRH-R) is a class II G protein-coupled receptor required for normal growth hormone (GH) synthesis and release from the pituitary, and for the normal growth and proliferation of somatotrophs within the pituitary.
openaire +2 more sources
Somatostatin (Growth hormone-release inhibiting hormone)
Clinics in Endocrinology and Metabolism, 1977The original studies of Krulich , Dhariwal and McCann (1968) established the concept that growth hormone secretion is regulated by means of two hypothalamic factors: growth hormone-releasing factor, the structure of which is unknown, and growth hormone-release inhibiting factor, a tetradecapeptide, which forms the basis of this chapter.
A, Gomez-Pan, R, Hall
openaire +2 more sources
The Journal of Clinical Endocrinology & Metabolism, 1990
Recent studies in the rat have shown that intracerebroventricular administration of CRH inhibited spontaneous pulsatile GH secretion and prevented GH-releasing hormone (GHRH)-induced GH release. We have studied the effect of CRH on GHRH-induced GH release in man.
Barbarino, Antonino +7 more
openaire +3 more sources
Recent studies in the rat have shown that intracerebroventricular administration of CRH inhibited spontaneous pulsatile GH secretion and prevented GH-releasing hormone (GHRH)-induced GH release. We have studied the effect of CRH on GHRH-induced GH release in man.
Barbarino, Antonino +7 more
openaire +3 more sources
Apomorphine-stimulated growth hormone release
The American Journal of Medicine, 1977Apomorphine, a dopaminergic receptor stimulant, was tested and compared in subemetic doses (0.76 mg subcutaneously) to levodopa (500 mg orally) as a stimulant of growth hormone release in 10 normal volunteer subjects (five male, five female). The administration of levodopa failed to cause a normal increment in serum growth hormone levels (greater than ...
J T, La Rossa, R, Agrin, J C, Melby
openaire +2 more sources
The growth hormone-releasing hormone receptor
2001Publisher Summary This chapter describes growth hormone (GH) as a polypeptide secreted by the somatotroph cells of the anterior pituitary gland, is the primary stimulator of linear growth in vertebrates and is involved in the regulation of protein and fat metabolism.
V I, DeAlmeida, K E, Mayo
openaire +2 more sources
Growth Hormone Releasing Hormone
1999Growth hormone (GH) synthesis and release is regulated by two hypothalamic peptides: somatostatin, which inhibits GH secretion, and growth hormone-releasing hormone (GHRH), which stimulates its release. Although somatostatin was the first to be identified in 1973 (1), the presence of a hypothalamic GH stimulating substance had been predicted in 1960 ...
Paul L. Hofman, O. H. Pescovitz
openaire +1 more source
GROWTH-HORMONE RELEASE BY GLUCAGON
The Lancet, 1969Abstract Significant increments in serum-growth-hormone levels were found within 2-3 hours of subcutaneous administration of 1 mg. glucagon to both men and women. The response to glucagon corresponded to some extent to the decline in glucose but the values of growth hormone bore no relationship to the magnitude of the decrease.
M L, Mitchell, M J, Byrne, J, Silver
openaire +2 more sources
Neuroendocrinology, 1989
The effects of opiate receptor antagonist naloxone on growth hormone (GH) release after growth hormone-releasing hormone (GHRH) administration were investigated, before or after feeding, at 13.00 h, in 20 obese women and in 10 normal women. When GHRH was administered to obese women before a meal at lunch time, the mean peak plasma GH levels were very ...
De Marinis, Laura +8 more
openaire +3 more sources
The effects of opiate receptor antagonist naloxone on growth hormone (GH) release after growth hormone-releasing hormone (GHRH) administration were investigated, before or after feeding, at 13.00 h, in 20 obese women and in 10 normal women. When GHRH was administered to obese women before a meal at lunch time, the mean peak plasma GH levels were very ...
De Marinis, Laura +8 more
openaire +3 more sources